Sanara MedTech, Inc. (SMTI)
32.08
+0.46
(+1.47%)
USD |
NASDAQ |
Nov 06, 10:27
Sanara MedTech Enterprise Value : 323.70M for Nov. 5, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 05, 2026 | 323.70M |
| November 04, 2026 | 330.32M |
| November 03, 2026 | 328.85M |
| November 02, 2026 | 327.93M |
| October 30, 2026 | 334.92M |
| October 29, 2026 | 335.70M |
| October 28, 2026 | 335.38M |
| October 27, 2026 | 335.01M |
| October 26, 2026 | 336.67M |
| October 23, 2026 | 334.64M |
| October 22, 2026 | 335.38M |
| October 21, 2026 | 334.37M |
| October 20, 2026 | 337.77M |
| October 19, 2026 | 337.77M |
| October 16, 2026 | 337.95M |
| October 15, 2026 | 355.70M |
| October 14, 2026 | 355.97M |
| October 13, 2026 | 356.16M |
| October 12, 2026 | 356.25M |
| October 09, 2026 | 355.51M |
| October 08, 2026 | 355.33M |
| October 07, 2026 | 355.33M |
| October 06, 2026 | 354.87M |
| October 05, 2026 | 354.87M |
| October 02, 2026 | 353.49M |
| Date | Value |
|---|---|
| October 01, 2026 | 353.77M |
| September 30, 2026 | 356.16M |
| September 29, 2026 | 355.70M |
| September 28, 2026 | 355.79M |
| September 25, 2026 | 355.42M |
| September 24, 2026 | 355.79M |
| September 23, 2026 | 356.25M |
| September 22, 2026 | 357.44M |
| September 21, 2026 | 356.43M |
| September 18, 2026 | 355.51M |
| September 17, 2026 | 354.68M |
| September 16, 2026 | 355.79M |
| September 15, 2026 | 355.88M |
| September 14, 2026 | 354.68M |
| September 11, 2026 | 354.13M |
| September 10, 2026 | 355.14M |
| September 09, 2026 | 355.14M |
| September 08, 2026 | 355.33M |
| September 04, 2026 | 352.39M |
| September 03, 2026 | 352.29M |
| September 02, 2026 | 353.03M |
| September 01, 2026 | 352.94M |
| August 31, 2026 | 353.77M |
| August 28, 2026 | 350.92M |
| August 27, 2026 | 351.01M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Intelligent Bio Solutions, Inc. | 2.721M |
| Anteris Technologies Global Corp. | 289.77M |
| 20/20 Biolabs, Inc. | -0.1454M |
| Quest Diagnostics, Inc. | 33.91B |
| Labcorp Holdings, Inc. | 36.03B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -0.4111M |
| Revenue (Quarterly) | 28.14M |
| Total Expenses (Quarterly) | 28.55M |
| EPS Diluted (Quarterly) | -0.0523 |
| Gross Profit Margin (Quarterly) | 90.76% |
| Profit Margin (Quarterly) | -1.46% |
| Earnings Yield | -11.56% |
| Operating Earnings Yield | 4.09% |
| Normalized Earnings Yield | -10.80 |